Cargando…

Patient experiences align with the familial hypercholesterolemia global call to action

OBJECTIVE: To explore alignment of perspectives from individuals and families with familial hypercholesterolemia (FH) to the FH Global Call to Action recommendations. METHODS: Interviews and focus groups were conducted with individuals and families with FH from multiple U.S. health systems and the F...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Laney K., Walters, Nicole, Brangan, Andrew, Ahmed, Catherine D., Wilemon, Katherine A., Campbell-Salome, Gemme, Rahm, Alanna K., Gidding, Samuel S., Sturm, Amy C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061613/
https://www.ncbi.nlm.nih.gov/pubmed/35517872
http://dx.doi.org/10.1016/j.ajpc.2022.100344
_version_ 1784698763738087424
author Jones, Laney K.
Walters, Nicole
Brangan, Andrew
Ahmed, Catherine D.
Wilemon, Katherine A.
Campbell-Salome, Gemme
Rahm, Alanna K.
Gidding, Samuel S.
Sturm, Amy C.
author_facet Jones, Laney K.
Walters, Nicole
Brangan, Andrew
Ahmed, Catherine D.
Wilemon, Katherine A.
Campbell-Salome, Gemme
Rahm, Alanna K.
Gidding, Samuel S.
Sturm, Amy C.
author_sort Jones, Laney K.
collection PubMed
description OBJECTIVE: To explore alignment of perspectives from individuals and families with familial hypercholesterolemia (FH) to the FH Global Call to Action recommendations. METHODS: Interviews and focus groups were conducted with individuals and families with FH from multiple U.S. health systems and the Family Heart Foundation community to capture lived experiences and to identify barriers to diagnosis, cascade testing, and treatment. Participant perspectives were examined and classified, according to their alignment to recommendations of the FH Global Call to Action. RESULTS: A total of 75 lived experiences were analyzed. Participants were majority female, mostly white, older, and well-educated. Participants most frequently mentioned recommendations were family-based care (84%) and screening, testing, & diagnosis (84%), followed by treatment (69%), advocacy (60%), cost & value (59%), awareness (56%), research & registries (43%), and severe & homozygous FH (11%). An average of 4.65 (SD 1.76) recommendations were mentioned. CONCLUSIONS: The FH Global Call to Action was driven by the persistent unmet needs of those living with FH in receiving a timely diagnosis, appropriate care, and support to prevent early morbidity and mortality. Patient- and family-centric perspectives suggest the FH Global Call to Action captures these concerns. Acting on recommendations, particularly improvements in screening and family-based care, will address patient, and public health, concerns.
format Online
Article
Text
id pubmed-9061613
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-90616132022-05-04 Patient experiences align with the familial hypercholesterolemia global call to action Jones, Laney K. Walters, Nicole Brangan, Andrew Ahmed, Catherine D. Wilemon, Katherine A. Campbell-Salome, Gemme Rahm, Alanna K. Gidding, Samuel S. Sturm, Amy C. Am J Prev Cardiol Original Research Contribution OBJECTIVE: To explore alignment of perspectives from individuals and families with familial hypercholesterolemia (FH) to the FH Global Call to Action recommendations. METHODS: Interviews and focus groups were conducted with individuals and families with FH from multiple U.S. health systems and the Family Heart Foundation community to capture lived experiences and to identify barriers to diagnosis, cascade testing, and treatment. Participant perspectives were examined and classified, according to their alignment to recommendations of the FH Global Call to Action. RESULTS: A total of 75 lived experiences were analyzed. Participants were majority female, mostly white, older, and well-educated. Participants most frequently mentioned recommendations were family-based care (84%) and screening, testing, & diagnosis (84%), followed by treatment (69%), advocacy (60%), cost & value (59%), awareness (56%), research & registries (43%), and severe & homozygous FH (11%). An average of 4.65 (SD 1.76) recommendations were mentioned. CONCLUSIONS: The FH Global Call to Action was driven by the persistent unmet needs of those living with FH in receiving a timely diagnosis, appropriate care, and support to prevent early morbidity and mortality. Patient- and family-centric perspectives suggest the FH Global Call to Action captures these concerns. Acting on recommendations, particularly improvements in screening and family-based care, will address patient, and public health, concerns. Elsevier 2022-04-18 /pmc/articles/PMC9061613/ /pubmed/35517872 http://dx.doi.org/10.1016/j.ajpc.2022.100344 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Original Research Contribution
Jones, Laney K.
Walters, Nicole
Brangan, Andrew
Ahmed, Catherine D.
Wilemon, Katherine A.
Campbell-Salome, Gemme
Rahm, Alanna K.
Gidding, Samuel S.
Sturm, Amy C.
Patient experiences align with the familial hypercholesterolemia global call to action
title Patient experiences align with the familial hypercholesterolemia global call to action
title_full Patient experiences align with the familial hypercholesterolemia global call to action
title_fullStr Patient experiences align with the familial hypercholesterolemia global call to action
title_full_unstemmed Patient experiences align with the familial hypercholesterolemia global call to action
title_short Patient experiences align with the familial hypercholesterolemia global call to action
title_sort patient experiences align with the familial hypercholesterolemia global call to action
topic Original Research Contribution
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061613/
https://www.ncbi.nlm.nih.gov/pubmed/35517872
http://dx.doi.org/10.1016/j.ajpc.2022.100344
work_keys_str_mv AT joneslaneyk patientexperiencesalignwiththefamilialhypercholesterolemiaglobalcalltoaction
AT waltersnicole patientexperiencesalignwiththefamilialhypercholesterolemiaglobalcalltoaction
AT branganandrew patientexperiencesalignwiththefamilialhypercholesterolemiaglobalcalltoaction
AT ahmedcatherined patientexperiencesalignwiththefamilialhypercholesterolemiaglobalcalltoaction
AT wilemonkatherinea patientexperiencesalignwiththefamilialhypercholesterolemiaglobalcalltoaction
AT campbellsalomegemme patientexperiencesalignwiththefamilialhypercholesterolemiaglobalcalltoaction
AT rahmalannak patientexperiencesalignwiththefamilialhypercholesterolemiaglobalcalltoaction
AT giddingsamuels patientexperiencesalignwiththefamilialhypercholesterolemiaglobalcalltoaction
AT sturmamyc patientexperiencesalignwiththefamilialhypercholesterolemiaglobalcalltoaction